Cambridge to lead new £20m MRC Hub to transform development of new medicines using stem cells and AI
Likely AI
The Hub builds on the expertise of the Cambridge Stem Cell Institute, in particular around advanced human in vitro models, including organoids and other stem cell-derived systems. It will combine this with AI-powered approaches, bioengineering and clinical research to create more accurate and predictive ways of studying human disease and testing potential treatments before they reach patients.The Hub will be led by Professor Matthias Zilbauer and Professor Bertie Göttgens from the Cambridge Stem Cell Institute (CSCI).
The Verdict
ClassificationLikely AI
ConfidenceHigh confidence
Analyzedtext
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/cd9dbfbe-dd9e-4252-9b5c-81e48e5e9fc7)